Medication-overuse Headache: 4 Years Follow up
NCT00918671 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2020-12-02
Summary
From 1 January 2004 to 31 December 2006 64 individuals with probable medication overuse headache were included in a randomized, 1-year open-labeled, multicentre study to evaluate the effect of early introduction of prophylactic treatment compared to abrupt withdrawal and with a control group (ClinicalTrials.gov number NCT00159588). In this follow-up, randomized patients still alive 4 years after primary inclusion time will be invited to a follow up interview, evaluating the headache complaints and the proportion of recurrent medication overuse.
Conditions
- Medication Overuse Headache
Interventions
- OTHER
-
No new specific intervention
No new specific intervention
Sponsors & Collaborators
-
Norwegian University of Science and Technology
lead OTHER
Principal Investigators
-
Knut Hagen, MD, PhD · Norwegian University of Science and Technology
Eligibility
- Min Age
- 22 Years
- Max Age
- 74 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2010-05-31
- Completion
- 2010-05-31
Countries
- Norway
Study Locations
More Related Trials
-
Is Detoxification Needed in Medication-overuse Headache?
NCT02993289 ·Status: UNKNOWN ·Phase: NA
-
Headache Provocation of People Who Are Unable to Have Headache
NCT04217668 ·Status: COMPLETED ·Phase: NA
-
Short Intervention for Medication Overuse Headache (MOH) - Pilot
NCT01078012 ·Status: COMPLETED ·Phase: NA
-
Melatonin for Migraine Prevention
NCT00849511 ·Status: COMPLETED ·Phase: PHASE2
-
Detoxification and Treatment of Subjects With Medication Overuse Headache
NCT00432549 ·Status: UNKNOWN ·Phase: PHASE4
-
Multiomics After Headache Provocation of People Who Are Unable to Have Headache
NCT04218760 ·Status: COMPLETED ·Phase: NA
-
Cabergoline as a Preventive Treatment for Chronic Migraine
NCT05525611 ·Status: COMPLETED ·Phase: NA
-
Effect of Acetyl-L-carnitine in Migraine
NCT01695317 ·Status: COMPLETED ·Phase: PHASE4
-
Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency
NCT04410536 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study Evaluating the Safety of Topiramate for the Prevention of Migraine
NCT00297336 ·Status: COMPLETED
-
A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache
NCT01946126 ·Status: COMPLETED
-
Drug and Non-Drug Treatment Of Severe Migraine
NCT00910689 ·Status: COMPLETED ·Phase: PHASE4
-
Endocrinological Profile in Patients With Medication-overuse Headache Before and After Withdrawal Therapy
NCT04090333 ·Status: COMPLETED
-
The Prolonged Use of Topiramate for Preventing Migraine Headaches
NCT00216619 ·Status: COMPLETED ·Phase: PHASE3
-
The Hemodynamic Effects of CGRP After Glibenclamide Administration in Healthy Volunteers
NCT04231617 ·Status: COMPLETED ·Phase: NA
-
CBT in Patients With Medication Overuse Headache
NCT01754571 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)
NCT05127954 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Oral Medications for the Management of Acute Migraine Headache in the Emergency Department
NCT05983354 ·Status: UNKNOWN ·Phase: NA
-
Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine
NCT01435941 ·Status: COMPLETED
-
The MOTS (Medication Overuse Treatment Strategy) Trial
NCT02764320 ·Status: COMPLETED ·Phase: NA
-
Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction
NCT00487578 ·Status: TERMINATED ·Phase: PHASE4
-
A Pragmatic Trial of Machine Prescription for Migraine
NCT06893874 ·Status: RECRUITING
-
The Effect of Sumatriptan and Placebo on CGRP Induced Headache
NCT03542357 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)
NCT06485336 ·Status: RECRUITING ·Phase: PHASE2
-
A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
NCT05133323 ·Status: COMPLETED ·Phase: PHASE2